Merck Invests in its Biotech Manufacturing Site in Bari

New production line for the aseptic filling of biotech medicines under isolator

04-Oct-2017 - Merck will invest €35 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy. The announcement was made as part of an event celebrating the 25th anniversary of the site and its leading role on the science and ...

Interface between syringe and device

Gerresheimer develops an interface for the integration of glass syringes in autoinjectors

03-Feb-2014 - The development of autoinjectors generally involves the integration of a pre-filled glass syringe into a plastic drug delivery device – a major challenge due to the different tolerances of both materials. Gerresheimer has now filed a patent application for its Gx G-Fix standard adapter for ...

Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration

21-Jun-2012 - Sartorius Stedim Biotech (SSB) and Bosch Packaging Technology (Bosch) announced a long-term global partnership agreement. The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of ...

Genzyme Successfully Meets First Milestones of FDA Consent Decree

All Filling and Finishing for U.S. Market Transferred Out of Allston Plant

30-Nov-2010 - Genzyme Corporation announced that the company has ended fill/finish operations within its Allston plant for products sold in the United States, as required by the FDA consent decree. All fill/finish activities for Cerezyme® (imiglucerase for injection), Myozyme® (alglucosidase alfa), Fabrazyme® ...

Vetter and Sentry BioPharma Services establish preferred partnership agreement

Supports a streamlined path from filling lab to clinic for early-stage study drugs

06-May-2010 - Vetter and Sentry BioPharma Servicesy announced that they have signed a preferred partnership agreement. Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The ...

Vetter wins the Axia Award

10-Feb-2010 - Vetter has been awarded the 2009 Axia Award for best customer relationship management. Conferred yearly by the global auditing and consulting firm Deloitte, the award is given to medium-sized companies from Baden-Wuerttemberg, Germany, for sustainable and successful management. Udo J. Vetter, ...

Dow Corning Ramps Up Pharmaceutical Grade Silicone Tubing Production in Response to Influenza Outbreak

09-Sep-2009 - In response to the urgent needs of pharmaceutical customers developing flu vaccines and anti-viral drugs used to battle potential pandemics, Dow Corning has ramped up tubing production capabilities. Dow Corning is able to produce additional pharmaceutical grade silicone tubing designed for ...

IDT Biologika Establishes New Corporation in the United States

03-Jun-2009 - IDT Biologika announced it has opened new offices outside Washington, DC in Herndon, VA to better serve pharmaceutical and biopharmaceutical customers in the United States. According to the company, the move comes in response to expanding business by IDT Biologika with multinational firms and ...

Time to bite the biotech bullet

18-Mar-2008 - The UK pharmaceutical industry could make more rapid progress in exploiting the potential of biotechnology if the scientists were better informed about the procedures for taking drugs to clinical trial and approval, and if regulatory affairs staff knew more about the science. That's the view of ...

Biogenerics and new technologies compete with 1st generation major protein products

21-Jun-2006 - The Business Intelligence firm La Merie S.L. reported that the US$ 32 bln market of major protein products with commencing patent expiry is endangered by generic products and by innovator solutions including engineered molecules and drug delivery solutions. Examples are the first biogeneric ...